SavedAdd your journal

Journals / Acta Medica Alanya / 2026 / Cilt: 9 Sayı: 1

Lipid lowering and additional pleiotropic effects of statins

Lipid düşürücü ve pleiotropik etkileriyle statinler

Ali Çoner(AKDENİZ ÜNİVERSİTESİ, ALANYA TIP FAKÜLTESİ, ALANYA TIP PR.)0000-0002-5711-8873
Ahmet Aslan(Alanya Alaaddin Keykubat Üniversitesi, Tıp Fakültesi)0000-0001-5797-1287
Pages
1–3
Publication Date
2025-04-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this paper, we aimed to discuss the pleiotropic effects of statins in addition to their protective effects in cardiovascular practice.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Statins are among the most commonly prescribed drugs worldwide today.
📊
Key Findings & Data:They are primarily effective in primary and secondary prevention of cardiovascular diseases with their cholesterol-lowering properties.
💡
Conclusion & Impact:In this paper, we aimed to discuss the pleiotropic effects of statins in addition to their protective effects in cardiovascular practice.
🔬Design:Editoryal
📍Scope:Comprehensive Sample
⚙️Variables:pleiotropik etki · statinler · antihiperlipidemik

Abstract

Statins are among the most commonly prescribed drugs worldwide today. They are primarily effective in primary and secondary prevention of cardiovascular diseases with their cholesterol-lowering properties. Recent studies have reported that statin derivatives have positive outcomes in different clinical conditions with different mechanisms, in addition to their lipid-lowering effects. In this paper, we aimed to discuss the pleiotropic effects of statins in addition to their protective effects in cardiovascular practice.

Özet

Dünya çapında statinler günümüzde en sık reçetelenen ilaçlar arasında yer almaktadırlar. Temel olarak kardiyovasküler hastalıklardan birincil ve ikincil korunmada kolesterol düşürücü özellikleriyle etki göstermektedirler. Son zamanlarda yapılan çalışmalarda statinler türevi ilaçlarla mevcut olan lipid düşürücü etkilerinin yanında farklı klinik durumlarda farklı mekanizmalarla olumlu sonlanımlar elde edildiği bildirilmiştir. Bu yazımızda statinlerin kardiyovasküler hastalıklardaki koruyucu etkileri dışında pleiotropic etkilerinden de bahsetmeyi amaçladık.

🔖

Cite This Article

Çoner, A., Aslan, A. (2025). Lipid lowering and additional pleiotropic effects of statins. Acta Medica Alanya, Cilt: 9 Sayı: 1, 1–3. https://ajindex.com/articles/1349478

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Okyay K. Pleiotropic effects of statins: New evidences. Turk Kardiyol Dern Ars. 2021; 49(7): 533-535. doi: 10.5543/tkda.2021.21211.
  2. Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021; 42(34): 3227-3337. doi: 10.1093/eurheartj/ehab484.
  3. Hanna EB. Dyslipidemia. In: Hanna EB, editor. Practical Cardiovascular Medicine. 2nd ed. Wiley Blackwell; 2022. p. 530-531.
  4. Raju MG, Pachika A, Punnam SR, Gardiner JC, Shishehbor MH, Kapadia SR, et al. Statin therapy in the reduction of cardiovascular events in patients undergoing intermediate-risk noncardiac, nonvascular surgery. Clin Cardiol. 2013; 36(8): 456-461. doi: 10.1002/clc.22135.
  5. Halvorsen S, Mehilli J, Cassese S, Hall TS, Abdelhamid M, Barbato E, et al. 2022 ESC guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery. Eur Heart J. 2022; 43(39): 3826-3924. Doi: 10.1093/eurheartj/ehac270.
  6. Liu JC, Lei SY, Zhang DH, He QY, Sun YY, Zhu HJ, et al. The pleiotropic effects of statins: a comprehensive exploration of neurovascular unit modulation and blood-brain barrier protection. Mol Med. 2024; 30(1): 256. doi: 10.1186/s10020-024-01025-0.
  7. Tripathi S, Gupta E, Galande S. Statins as anti-tumor agents: A paradigm for repurposed drugs. Cancer Rep (Hoboken). 2024; 7(5): e2078. doi: 10.1002/cnr2.2078.
  8. Giorello MB, Marks MP, Osinalde TM, Padin MDR, Wernicke A, Calvo JC, et al. Post-surgery statin use contributes to favorable outcomes in patients with early breast cancer. Cancer Epidemiol. 2024; 90: 102573. doi: 10.1016/j.canep.2024.102573.
  9. Marom H, Khan MA, Darvish N, Tornetta Iii P, Khoury A, Weil YA, et al. ß-caryophyllene and statins in bone fracture healing-a narrative review. Orthop Res Rev. 2025; 17: 31-42. doi: 10.2147/ORR.S506427.
  10. Li XH, Qian SD, Chen D, Li ZZ, Chen KY, Pan YP, et al. A new mechanism in steroid-induced osteonecrosis of the femoral head and the protective role of simvastatin. Exp Cell Res. 2025; 446: 114471. doi: 10.1016/j.yexcr.2025.114471.
  11. Yang Z, Liu H, Li D, Xie X, Qin T, Ma J, et al. The efficacy of statins in preventing glucocorticoid-related osteonecrosis in animal models: A meta-analysis. Bone Joint Res. 2016; 5: 393-402. doi: 10.1302/2046-3758.59.2000500.
  12. Lee YJ, Cui Q, Koo KH. Is there a role of pharmacological treatments in the prevention or treatment of osteonecrosis of the femoral head?: a systematic review. J Bone Metab. 2019; 26: 13-18. doi: 10.11005/jbm.2019.26.1.13.